valganciclovir hydrochloride is a Oral For Solution in the Human Prescription Drug category. It is labeled and distributed by Novadoz Pharmaceuticals Llc. The primary component is Valganciclovir Hydrochloride.
Product ID | 72205-019_614ff447-7e5f-4ea6-ba85-ec1f6497b360 |
NDC | 72205-019 |
Product Type | Human Prescription Drug |
Proprietary Name | valganciclovir hydrochloride |
Generic Name | Valganciclovir Hydrochloride |
Dosage Form | For Solution |
Route of Administration | ORAL |
Marketing Start Date | 2022-02-17 |
Marketing Category | ANDA / |
Application Number | ANDA210169 |
Labeler Name | Novadoz Pharmaceuticals LLC |
Substance Name | VALGANCICLOVIR HYDROCHLORIDE |
Active Ingredient Strength | 50 mg/mL |
Pharm Classes | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], DNA Polymerase Inhibitors [MoA], Nucleoside Analog Antiviral [EPC], Nucleoside Analog [EXT] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2022-09-14 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
27241-159 | Valganciclovir hydrochloride | Valganciclovir hydrochloride |
43598-356 | valganciclovir hydrochloride | valganciclovir hydrochloride |
63739-357 | VALGANCICLOVIR HYDROCHLORIDE | VALGANCICLOVIR HYDROCHLORIDE |
65862-753 | VALGANCICLOVIR HYDROCHLORIDE | VALGANCICLOVIR HYDROCHLORIDE |
70010-051 | VALGANCICLOVIR HYDROCHLORIDE | VALGANCICLOVIR |
70069-810 | VALGANCICLOVIR HYDROCHLORIDE | VALGANCICLOVIR |
72205-019 | valganciclovir hydrochloride | valganciclovir hydrochloride |
0004-0039 | Valcyte | valganciclovir hydrochloride |
0603-6330 | Valganciclovir | Valganciclovir hydrochloride |
31722-837 | VALGANCICLOVIR | VALGANCICLOVIR HYDROCHLORIDE |
42291-875 | Valganciclovir | Valganciclovir hydrochloride |
63629-2288 | Valganciclovir | Valganciclovir hydrochloride |
64380-153 | Valganciclovir | Valganciclovir hydrochloride |
0591-2579 | Valganciclovir hydrochloride for Oral | Valganciclovir hydrochloride |